Studies with bone marrow stromal cell lines showed high levels of expression of CCN1 and knockdown of CCN1 using antibodies or RNAi led to increased sensitivity to chemotherapy in AML-stromal cell co-cultures (Long et al. 2015). The gene discussed is CCN1; the disease is acute myeloid leukemia.